Advanced Search

Executive Order Amending Executive Order On Euphoriant Substances

Original Language Title: Bekendtgørelse om ændring af bekendtgørelse om euforiserende stoffer

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.

Publication of the amendment of the notification of the eup-for-use substances

§ 1

Notice no. 749 of 1. July 2008 on euphoria substances, as amended by the notice No 1329 by 18. December 2008 and Notice no. 174 of 10. In March 2009, the following changes are made :

1. I § 5 pasted as paragraph 2 :

" Stop. 2. The Board of Directions may, after obtained from the Health Services, allow municipal, regional and private institutions to authorize, cf. section 142 of the health officer, to receive and possess the eup-forisining agent listed on List A as No 3, as part of the medical treatment of drug abuse. The governing board may lay down the terms of the permit. `

2. § 26 ITREAS :

" § 26. The governing board shall supervise the operation of pharmacists with eup-forisining funds.

Paragraph 2. The Food Management Board shall supervise the activities of veteriners with eup-forisining funds.

Paragraph 3. The governing board shall supervise persons, undertakings and laboratories authorised by the Medicinal Products Agency for the Agency ' s activities with eup-for-use funds.

Paragraph 4. The governing board may supervise the state ' s natural scientific, medical and technical laboratories and institutions in the case of their business with eup-for-use funds.

Paragraph 5. The governing board shall supervise the institutions which have received it in section 5 (5). The consent of the institutions, the handling and storage of the institutions referred to in List A as referred to in List A as referred to in List A as referred to in the Community, shall be subject to authorization. 3.

Paragraph 6. The Medical Board shall conduct the action referred to in paragraph 1. 3-5 referred to as often as required. The governing board has unhindered access to the premises, opinions, books and business documents relating to the business referred to. The person, the holder, the operator of the establishment, the director of the laboratory or the institution shall be obliged to supply the information relating to the company with euphoria, which the LeageBoard may wish.

Paragraph 7. In the case of the oversight of the Medicinal Board of Medicinal Products, they shall be remedied immediately.

Paragraph 8. The governing board may lay down detailed rules on the rules laid down in paragraph 1. 3-5 mentioned supervision. ` ;

§ 2

The announcement will enter into force on the 14th. May 2009.

The Ministry of Health and Prevention, the 11th. May 2009 Jakob Axel Nielsen / Lars Petersen